��

��. ��:

30-Jul-2000

�� , 16(5), ��-�� 1999, 492-496

��

�� HTLV-I-II
��
��

�. ��,¹ �. ��,² �. ��,² �. ��,¹ �. ��¹

¹�' �� , �� . ��
²��

�� : ��, �� HTLV-I-II, ��.

O� �� HTLV-I �� , �� , �� .¹ � �� HTLV-I, �� 20 ��, �� , �� .²

�� , ��, ��, �� , ��, �� , �� , �� .^3�6 �� HTLV (HERN)⁷ �� HTLV-I �� , �� HTLV-I� �� .

�� , � �� HTLV-I �� .^7,8 �� , �� , � �� HTLV-I �� 0,005% (2/100.000) �� HIV.⁹ �� , ��, ��, ��, �� , �� HTLV-I-�� , �� .⁷ �� HTLV.⁷

�� HTLV-I �� , �� 100 �� .² �� , �� HIV �� HTLV-I, �� 2 (HSV-2), �� (HBcAg) �� , �� , �� HSV-2, �� HIV-1 �� HTLV-I.¹⁰ �� HTLV-I �� ,^11�13 �� Chen et al¹⁴ �� Tax �� HTLV-I, �� , �� .

�� aplan et al¹⁵ �� HTLV �� . �� , �� HTLV �� , �� HTLV, �� HTLV-I �� 12�18 �� , �� , �� (�� ). �� HTLV-I.^16,17

�� , �� ,¹⁸ �� , �� HTLV-I �� .

�� 

�� , �� -HTLV-I �� HTLV-I �� . �� -HTLV-I-�� 54.017 �� 359 ��, �� HTLV �� . �� , � �� .

� �� -HTLV-I-�� Abbott �� Murex �� Western blot 2.4 �� Innolia. �� 12�18 �� 18�30 �� . �� (�� 1:5 �� 1:3125) �� .

��

�� , �� . �� 820 �� 750 �� HTLV �� 1981, �� . � �� HTLV �� 1987 �� 1989, ��.

�� 3 �� , �� .

� �� -HTLV-I 18 �� , �� . �� (��. 1). �� 120 ��, �� (�� 36�8 ��) (��. 2).

��

� �� HTLV-I-�� HTLV-I �� .^7,19�21 �� 25% �� 5%, �� HTLV-I-�� .^7,20,22 �� Courtois et al²² �� , �� 849 �� , �� HTLV-I-��, �� 3 �� (0,9%) �� 2 ��-�� (0,8%). �� Tosswill²³ �� Banatrala²⁴ �� , �� 0,3�1,9% �� .

�� , �� -HTLV-I-��-�� . �� , �� , �� HTLV-I �� , �� 12�18 ��.^16,17

�� , � �� , �� HTLV-I �� ,¹⁸ �� , �� 0,008% �� -HTLV-I �� 0,001% �� -HTLV-I�. � �� 38 �� . �� , �� 42 ��.

� �� , 18 �� . � �� , �� .

� �� 16,7%. �� , �� , �� .

�� , �� HIV-�� . �� , ��, �� .

�� , �� , �� . �� , ��, ��, ��.

�� , �� , �� , �� .²⁶

� �� -HTLV-I-II �� HTLV-I-��. � �� , �� 1997 �� . �� , � �� -��, �� , �� . �� , �� HTLV-I-��, �� HTLV-I-�� (�� -��, �� , �� , �� Sj�gren �.��.) �� .²⁵

��

WONG-STAAL F, GALLO RC. Human T-lymphotropic retrovirus. Natu re 1985, 317:395�403
BLATTNER WA, NOMURA A, CLARK JW, HO GY, NAKAO U, GALLO R ET AL. Modes of transmission and evidence for viral latency from studies of human T-cell lymphotropic virus I in Japanese migrant popu lations in Hawaii. Proc Natl Acad Sci USA 1986, 83:4895�4898
MUELLER N, OKAYAMA A, STUVER S, TACHIBANA N. Findings from the Miyazaki Cohort Study. J Acquir Immune Defic Syndr Hum Retro virol 1996, 13(Supp 1):52�57
STUVER SO, TACHIBANA N, OKAYAMA A, SHIOIRI S, TSUNETOSHI Y, TSUDA K ET AL. Heterosexual transmission of human T-cell leuke mia/lymphoma virus type I among married couples in Southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis 1993, 167:57�65
LOVEDAY C, MERCEY D. The prevalence of human retroviral infections in female patients attending a central London sexually transmitted disease clinic: 1985�1990. Genitourin Med 1993, 69:31� 34
RODRIGUEZ EM, DE MOYA EA, GUERRERO E, MONTERROSO ER, QUINN TC, PUELLO E ET AL. HIV-1 and HTLV-I sexually transmitted disease clinics in the Dominican Republic. J Acquir Immune Defic Syndr 1993, 6:313�318
THE HTLV EUROPEAN RESEARCH NETWORK. Seroepidemiology of the human T-cell leukemia-lymphoma viruses in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13:68�77
COUROUCE AM, PILLONEL J, LEMAIRE JM, SAURA C. HTLV testing in blood transfusion. Vox Sang 1998, 74(Suppl 2):165�169
TAYLOR GP. The epidemiology of HTLV-I in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13:68�77
BOULOS R, RUFF AJ, NAHMIAS A, HOLT E, HARRISON L, MAGDER L ET AL. Herpes simplex virus type 2 infection, syphilis, and hepatitis B virus infection in Haitian women with human immunodeficiency virus type 1 and human T-lymphotropic virus type I infections. The John Hopkins University (JHU)/Center pour le Delevelopment et la Sante (CDS) HIV Study Group. J Infect Dis 1992, 166: 418�420
ZACHAROPOULOS VR, PHILLIPS DM. Cell-mediated HTLV-I infection of a cervix-derived epithelial cell line. Microb Pathogen 1997, 23: 225�233
SULLIVAN MT, WILLIAMS AE, FANG CT, NOTARI EP, POIESZ BJ, EHRLICH GD. Human T-lymphotropic virus (HTLV) types I and II infection in sexual contacts and family members of blood donors who are seropositive for HTLV type I or II. American Red Cross HTLV-I-II Collaborative Study Group. Transfusion 1993, 33:585�590
TAKE H, UMEMOTO M, KUSUHARA K, KURAYA K. Transmission routes of HTLV-I: an analysis of 66 families. Jpn J Cancer Res 1993, 84: 1265�1267
CHEN YM, OXAYAMA A, LEE TH, TACHIBANA N, MUELLER N, ESSEX M. Sexual transmission of human T-cell leukemia virus type I associated with the presence of anti-Tax antibody. Proc Natl Acad Sci USA 1991, 88:1182�1186
KAPLAN JE, KHABBAZ RF, MURPHY EL, HERMANSEN S, ROBERTS C, LAL R ET AL. Male-to-female transmission of human T-cell lymphotro pic virus types I and II: association with viral boad. The Retrovi rus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:193�201
�� , �� , �� , �� , RICHARDSON C, �� . �� HTLV I/II �� . �� 1993, 63:502�507
POLITIS C, ECONOMIDOU I, PAPADOYANNAKI N, RICHARDSON C, FRAGATOU S, VRETTOU E ET AL. HTLV-I infection in blood donors, thalassemic patients in Greece. Arch Hell Med 1996, 13:388�392
�� , �� , �� , �� , �� , �� . �� -HTLV-I-II �� . �� . ��  1999, 16:478�485
VLAHOV D, KHABBAZ RF, COHN S, GALAI N, TAYLAR E, KAPLAN JE. Incidence and risk factors for human T-lymphotropic virus type II (HTLV-II) seroconversion among injecting drug users in Baltimore, Maryland. J AIDS, 7:841�847
VAN DEN HOCK JAR, AI EJM, HUISMAN JG, GOUDSMIT J, GOUTINHO RA. Low prevalence of human �-cell leukemia virus I and II infection among drug users in Amsterdam, the Netherlands. J Med Virol 1991, 34:100�103
MURPHY EL. The clinical epidemiology of human T-lymphotropic virus type II (HTLV-II). J Acquir Immune Defic Syndr Hum Retrovi rol 1996, 13(Suppl 1):S215�S219
COURTOIS F, BARIN F, LARSEN M, BRASSARD X, MASSELIN A, ENGELMAN P. HTLV I/II infection in pregnant women in Paris. Lancet 1990, 335:1103
TOSSWILL JHC, ADES AE, PECKHAM C, MORTIMER P, WEBER JN. Infection with HTLV I in patients attending an antenatal clinic in London. Br Med J 1990, 301:95�96
BANARTALA JE, CHRYSTIE IL, PALMER SI, KENNEY A. Retrospective stu dy of HIV, hepatitis B and HTLV-I infection at a London antenatal clinic. Lancet 1990, 335:859-860
MANNS A, BLATTNER WA. The epidemiology of the human T-cell lymphotropic virus type I and type II: etiologic role in human disease. Transfusion 1991, 31:67�75
POLITIS C, RICHARSDON CI. Perceptions of the risk of HIV infection through sinus blood in Greece. Vox Sang 1997, 72:251� 252

� 2000, �� c��